Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3493 | 1893 | 41.0 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OSTEOPONTIN | Author keyword | 559 | 46% | 47% | 895 |
2 | OSTEOPONTIN OPN | Author keyword | 60 | 80% | 2% | 37 |
3 | OPN | Author keyword | 12 | 33% | 2% | 31 |
4 | ETA 1 | Author keyword | 11 | 78% | 0% | 7 |
5 | SVVYGLR | Author keyword | 6 | 80% | 0% | 4 |
6 | TUMOR BIOL ANGIOGENESIS NANOMED | Address | 6 | 80% | 0% | 4 |
7 | SECRETED PHOSPHOPROTEIN | Author keyword | 4 | 75% | 0% | 3 |
8 | PLASMA OSTEOPONTIN | Author keyword | 3 | 100% | 0% | 3 |
9 | PROGRAMA POS STRICTO SENSU ONCOL INCA | Address | 3 | 100% | 0% | 3 |
10 | SECRETED PHOSPHOPROTEIN 1 SPP1 | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OSTEOPONTIN | 559 | 46% | 47% | 895 | Search OSTEOPONTIN | Search OSTEOPONTIN |
2 | OSTEOPONTIN OPN | 60 | 80% | 2% | 37 | Search OSTEOPONTIN+OPN | Search OSTEOPONTIN+OPN |
3 | OPN | 12 | 33% | 2% | 31 | Search OPN | Search OPN |
4 | ETA 1 | 11 | 78% | 0% | 7 | Search ETA+1 | Search ETA+1 |
5 | SVVYGLR | 6 | 80% | 0% | 4 | Search SVVYGLR | Search SVVYGLR |
6 | SECRETED PHOSPHOPROTEIN | 4 | 75% | 0% | 3 | Search SECRETED+PHOSPHOPROTEIN | Search SECRETED+PHOSPHOPROTEIN |
7 | PLASMA OSTEOPONTIN | 3 | 100% | 0% | 3 | Search PLASMA+OSTEOPONTIN | Search PLASMA+OSTEOPONTIN |
8 | SECRETED PHOSPHOPROTEIN 1 SPP1 | 3 | 100% | 0% | 3 | Search SECRETED+PHOSPHOPROTEIN+1+SPP1 | Search SECRETED+PHOSPHOPROTEIN+1+SPP1 |
9 | THROMBIN CLEAVED OSTEOPONTIN | 3 | 100% | 0% | 3 | Search THROMBIN+CLEAVED+OSTEOPONTIN | Search THROMBIN+CLEAVED+OSTEOPONTIN |
10 | SPP1 | 3 | 25% | 1% | 10 | Search SPP1 | Search SPP1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLASMA OSTEOPONTIN | 112 | 75% | 4% | 82 |
2 | ETA 1 | 111 | 88% | 3% | 52 |
3 | SECRETED PHOSPHOPROTEIN | 106 | 79% | 4% | 68 |
4 | BONE SIALOPROTEIN | 35 | 23% | 7% | 136 |
5 | BOVINE OSTEOPONTIN | 32 | 85% | 1% | 17 |
6 | INTRACELLULAR OSTEOPONTIN | 32 | 63% | 2% | 32 |
7 | SECRETED PHOSPHOPROTEIN I | 32 | 78% | 1% | 21 |
8 | MICE LACKING OSTEOPONTIN | 26 | 61% | 1% | 28 |
9 | NONPHOSPHORYLATED FORMS | 26 | 69% | 1% | 22 |
10 | BONE PHOSPHOPROTEIN | 24 | 82% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Osteopontin: Versatile modulator of liver diseases | 2014 | 14 | 66 | 83% |
Osteopontin as a therapeutic target for cancer | 2014 | 13 | 98 | 80% |
Osteopontin - A multifunctional molecule regulating chronic inflammation and vascular disease | 2007 | 274 | 103 | 78% |
Osteopontin: Role in immune regulation and stress responses | 2008 | 209 | 129 | 81% |
Osteopontin: role in cell signaling and cancer progression | 2006 | 301 | 77 | 65% |
Role of osteopontin in tumour progression | 2004 | 244 | 39 | 92% |
Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases | 2011 | 49 | 89 | 75% |
Role of the metastasis-promoting protein osteopontin in the tumour microenvironment | 2010 | 58 | 104 | 74% |
Osteopontin: An Effector and an Effect of Tumor Metastasis | 2010 | 55 | 183 | 73% |
Osteopontin: regulation in tumor metastasis | 2008 | 150 | 210 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TUMOR BIOL ANGIOGENESIS NANOMED | 6 | 80% | 0.2% | 4 |
2 | PROGRAMA POS STRICTO SENSU ONCOL INCA | 3 | 100% | 0.2% | 3 |
3 | MATRIX MED | 3 | 28% | 0.5% | 10 |
4 | CANC POLIO FUND S | 3 | 26% | 0.5% | 9 |
5 | DIPARTIMENTO ASSISTENZIALE OTORINOLARINGOIATRIA | 2 | 67% | 0.1% | 2 |
6 | ENDOCRINOL METABRUIJIN HOSP | 2 | 67% | 0.1% | 2 |
7 | FORSYTH DENT | 2 | 67% | 0.1% | 2 |
8 | INTERDISCIPLINAR RIO DAS OSTRAS RIR | 2 | 67% | 0.1% | 2 |
9 | NELSON S | 2 | 15% | 0.7% | 13 |
10 | CELL MATRIX FRONTIER | 2 | 50% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000169143 | BONE SIALOPROTEIN//PHOSPHOPHORYN//DENTIN MATRIX PROTEIN 1 |
2 | 0.0000053539 | SPARC//OSTEONECTIN//BM 40 |
3 | 0.0000042976 | CALCIUM OXALATE//BIOMINERALIZAT LITHIASIS//CALCIUM OXALATE CRYSTALLIZATION |
4 | 0.0000040929 | TARTRATE RESISTANT ACID PHOSPHATASE//SPECIAL HEMATOL//TARTRATE RESISTANT |
5 | 0.0000039541 | NEPHRONECTIN//VLA 1//ALPHA 8 INTEGRIN |
6 | 0.0000038971 | TIP30//EASTERN HOSP HEPATOBILIARY SURG//CC3 |
7 | 0.0000037845 | OSTEOPROTEGERIN//VASC MED ATHEROTHROMBOSIS//INTERDEPARTMENTAL REGENERAT MED |
8 | 0.0000037564 | VASCULAR CALCIFICATION//MATRIX GLA PROTEIN//KEUTEL SYNDROME |
9 | 0.0000034360 | CD44//CD44V6//CD44 ISOFORMS |
10 | 0.0000028549 | MARROW FIBROBLASTS//OSTEOPROGENITORS//OSTEOBLASTIC MARKERS |